Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Bone Turnover Markers Show Link to Iliac Histomorphometry in Older Women

Reuters Staff  |  November 12, 2015

NEW YORK (Reuters Health)—Although histomorphometry of iliac bone gives precise results, bone turnover markers provide a better reflection of the overall skeleton in untreated postmenopausal osteoporotic women, according to French researchers.

Bone histomorphometry allows study of bone remodeling at the basic structural unit level, Dr. Pascale Chavassieux and colleagues at the University of Lyon note in the Journal of Clinical Endocrinology and Metabolism, online Oct. 27.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

However, the most sensitive and widely used markers of formation are serum osteocalcin, the bone isoenzyme of alkaline phosphatase (bone ALP) and the procollagen type 1 N-terminal propeptide (P1NP), they add.

To investigate the correlation between these approaches, the researchers conducted a post-hoc analysis of data from a previously published trial involving 371 women with at least one osteoporotic fracture. The team examined transilliac bone biopsies and blood samples.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bone ALP and P1NP significantly correlated with both the static and dynamic parameters of bone formation. In addition, the resorption marker C-terminal crosslinking telopeptide of collagen type 1 significantly correlated with all resorption parameters.

“Bone turnover markers were significantly but modestly associated with bone turnover parameters measured at the tissue level in cancellous or endosteal compartments of iliac bone,” the researchers write.

They conclude that bone turnover markers “reflect the turnover of the entire skeleton, including the periosteal, cortical, endocortical and cancellous compartments when the histomorphometric parameters assess a small part of the iliac crest.”

Thus, they add, “Iliac cancellous bone provides useful information on the bone architecture, turnover and mineralization but variability exists across the skeletal sites.”

Dr. Chavassieux did not respond to requests for comment.

Share: 

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:boneIliac HistomorphometryOsteoporosispostmenopauseWomen

Related Articles

    Build Up Bone

    June 1, 2007

    Current management of osteoporosis

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

    Changes in Bone Markers Predict Fracture Reduction with Anti-Resorptive Drug

    January 17, 2018

    NEW YORK (Reuters Health)—Treatment-related changes in bone formation markers predict vertebral-fracture reduction with anti-resorptive drug therapy, according to a meta-regression analysis of 14 clinical trials. “These results may be useful for the development of new osteoporosis treatments or when considering new populations or dosing regimens with existing treatments,” Dr. Douglas C. Bauer from the University…

    Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD

    July 7, 2020

    Suggestions on how to assess risk and manage bone issues in chronic kidney disease patients are offered…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences